Staar Surgical Company
Research Staar Surgical Company (STAA) on Bullrun: market cap USD 1.46B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerSTAA
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- CurrencyUSD
- Market capUSD 1.46B
- Financial periodFY2026
- RevenueUSD 239.44M
- Revenue growth-23.7%
- Net income-USD 80.45M
- Free cash flow-USD 40.05M
- Gross margin76.2%
Valuation Snapshot
latest market cap is USD 1.46B.
About Staar Surgical Company
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells phakic implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company offers implantable collamer lens product family (ICLs) comprising EVO ICL, EVO+ ICL, EVO Visian ICL, and EVO Viva ICL for use in refractive surgery for the treatment of visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia.
Frequently asked questions
What is Staar Surgical Company's market cap?
Staar Surgical Company's market capitalization is USD 1.46B.
What does Staar Surgical Company do?
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells phakic implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye.